TSXV:CLAS.H - Post by User
Post by
yorgosGKon Apr 18, 2018 6:05pm
256 Views
Post# 27907578
Useful data
Useful data I quickly put together an excel with all of the sell trades from broker 018 (Echelon Wealth).
You can downlaod it via the link below. They have been selling their debenture shares since March at all sorts of market prices. I have added the total averages and total shares sold (including today's session) at the top of the excel.
No one knows what they will do (or if they will do anything)....Heck they would of already got rid of all of them if they wanted to by now. Since by the looks of it, they are strategically letting go of them like this, we wll be able to absorb without a problem, the drop was simply the short positions taken. This stock has the liquid to absorb a measily 5M$ loan deal (I mean give me a break look at our competitors......all well over 200M shares-out and MILLIONS in debt with over $1 SP).
I think what will happen is we get a good fair market price back before they exercise the warrants and at that time period we will finally get the news to help with the share price that will shake the MJ sector. Lets hope this happens soon! (which I think it most lickely will).
Echelon essentially made a 5M investment into KALY - funds that our company needed to start phase 2 with (which is literally peanuts to what we are going to be). I can almost garuntee the shorts will cover the warrants and we can put this thing to rest once and for all. After all the longer Echelon holds the more they make...don't forget!
The Convertible Debentures will bear interest from the date of closing at 9.0% per annum, payable semi-annually in arrears on June 30, 2018 and thereafter semi-annually on the last day of June and December in each year
Anywho - there is no telling exactly what will happen (althought many signs point to a healthy recovery +). I do know %100 that KALY is a winner. CBD to cure and prevent GvHD is patented and will ultimatly get FDA approval. This is just the begining...Just look at the before and afters in their corprate guide! Not even going to get into the potential for CBD + Naproxon for pain killer. And finally the news - who knows!....I'd bet will be bigger than the pain killer NR.
For what its worth:
018 Sales - KALYl